Additionally, in MASLD, aberrant upregulation of hepatic PPARγ increases the expression of fatty acid transporters, including fatty acid binding protein 1 (FABP1) and CD36, leading to lipid accumulation in hepatocytes [19, 20, 21]. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.